Medtronic pulls Infuse product from Australia amid probe

Medtronic's Infuse Bone Graft has been withdrawn from the Australia market after a whistleblower report to regulators that it was being sold without an accompanying product required for safety.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.